Vol 6, No 3 (June 29, 2017): Translational Lung Cancer Research (Malignant Pleural Mesothelioma: Updates and New Directions)

Preface

The promise of emerging developments and concepts in mesothelioma

Chuong D. Hoang

PDF Pages: 246-247 Full Text (1751) Open Access

Review Article

In vitro experimental models of mesothelioma revisited

Anand Singh, Nathanael Pruett, Chuong D. Hoang

PDF Pages: 248-258 Full Text (4229) Open Access

Diagnostic and prognostic biomarkers for malignant mesothelioma: an update

Zhongjian Chen, Giovanni Gaudino, Harvey I. Pass, Michele Carbone, Haining Yang

PDF Pages: 259-269 Full Text (7223) Open Access

BAP1, a tumor suppressor gene driving malignant mesothelioma

Mitchell Cheung, Joseph R. Testa

PDF Pages: 270-278 Full Text (12649) Open Access

Intraoperative near-infrared imaging of mesothelioma

Gregory Thomas Kennedy, Andrew Newton, Jarrod Predina, Sunil Singhal

PDF Pages: 279-284 Full Text (4303) Open Access

Intraoperative adjuncts for malignant pleural mesothelioma

Warren Ho Chan, David J. Sugarbaker, Bryan M. Burt

PDF Pages: 285-294 Full Text (3955) Open Access

Novel systemic therapy against malignant pleural mesothelioma

Michael R. Mancuso, Joel W. Neal

PDF Pages: 295-314 Full Text (9216) Open Access

Immunotherapy for malignant pleural mesothelioma: current status and future directions

Jordan Dozier, Hua Zheng, Prasad S. Adusumilli

PDF Pages: 315-324 Full Text (5868) Open Access

Radio-immunotherapy and chemo-immunotherapy as a novel treatment paradigm in malignant pleural mesothelioma

Licun Wu, Marc de Perrot

PDF Pages: 325-334 Full Text (5039) Open Access

Drug development against the hippo pathway in mesothelioma

Gavitt A. Woodard, Yi-Lin Yang, Liang You, David M. Jablons

PDF Pages: 335-342 Full Text (8314) Open Access

Targeting eukaryotic protein translation in mesothelioma

Robert A. Kratzke

PDF Pages: 343-349 Full Text (2604) Open Access

Targeting the epigenome in malignant pleural mesothelioma

Kaitlin C. McLoughlin, Andrew S. Kaufman, David S. Schrump

PDF Pages: 350-365 Full Text (6003) Open Access

Original Article

The use of TCP based EUD to rank and compare lung radiotherapy plans: in-silico study to evaluate the correlation between TCP with physical quality indices

Abdulhamid Chaikh, Jacques Balosso

PDF Pages: 366-372 Full Text (5914) Open Access

Review Article

Predictive biomarkers of immunotherapy for non-small cell lung cancer: results from an Experts Panel Meeting of the Italian Association of Thoracic Oncology

Cesare Gridelli, Andrea Ardizzoni, Massimo Barberis, Federico Cappuzzo, Francesca Casaluce, Romano Danesi, Giancarlo Troncone, Filippo De Marinis

PDF Pages: 373-386 Full Text (8243) Open Access

Case Report

Do we really care about incidental lung nodules?—Review of atypical lung carcinoid and a proposal for systematic patient follow up

Henal Motiwala, Itisha Bansal, Pradeep Goyal, Olena Dorokhova, Yogesh Kumar, Thomas D. Olsavsky, Albert DiMeo, Nishant Gupta

PDF Pages: 387-392 Full Text (6535) Open Access

Editorial

Combination MET- and EGFR-directed therapy in MET-overexpressing non-small cell lung cancers: time to move on to better biomarkers?

Fernando C. Santini, Siddharth Kunte, Alexander Drilon

PDF Pages: 393-395 Full Text (4813) Open Access

Disclosure:

The focused issue “Malignant Pleural Mesothelioma: Updates and New Directions” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Chuong D. Hoang served as the unpaid Guest Editor for the focused issue.